Correlation Between Edgewise Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Edgewise Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Edgewise Therapeutics and ProMIS Neurosciences
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and ProMIS is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.62 times more return on investment than ProMIS Neurosciences. However, Edgewise Therapeutics is 1.61 times less risky than ProMIS Neurosciences. It trades about 0.08 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about 0.0 per unit of risk. If you would invest 798.00 in Edgewise Therapeutics on September 3, 2024 and sell it today you would earn a total of 2,502 from holding Edgewise Therapeutics or generate 313.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. ProMIS Neurosciences
Performance |
| Timeline |
| Edgewise Therapeutics |
| ProMIS Neurosciences |
Edgewise Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Edgewise Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |